-
Cotation en bourse
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemLire la suiteSeamless listing, trading, clearing and settlement for fixed income
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suite
Trade Mini Bond Futures on main European Government Bonds
-
Clearing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemLire la suite
Seamless listing, trading, clearing and settlement for fixed income
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Données de marché
-
Indices
Access the white paperNext generation of indicesLire la suiteThis white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
Introduction en bourse de Valbiotis
23/06/2017
Introduction en bourse de Valbiotis sur Euronext
Sébastien Peltier, Directeur Général de Valbiotis, sonne la cloche qui marque l'ouverture des marchés à Paris.
Valbiotis est une société biopharmaceutique spécialisée dans la recherche et le développement de produits préventifs et thérapeutiques basés sur des complexes polymoléculaires indiqués à des stades précis d’évolution de pathologies métaboliques chroniques telles que le diabète de type 2, l’obésité, la dyslipidémie ou encore le NASH (Stéatose Hépatique Non-Alcoolique).